Ozempic is coming to India.

Why should this matter to you? Because this world-famous, much-discussed diabetes treatment has also become a global weight-loss phenomenon. And now it could soon be available on your local pharmacy shelves.

The once-a-week injection by Danish firm Novo Nordisk is headed for Indian shelves after being cleared by the Central Drugs Standard Control Organisation (CDSCO) — India’s drug regulator — for use in patients with type 2 diabetes. Its arrival comes at a time when demand for weight-management therapies is surging in India.

Ozempic is the diabetes drug that has celebrities and social media buzzing — not for controlling Type-2 diabetes, per se, but for promoting weight loss. In fact, it has built a reputation worldwide, more for triggering weight loss on a scale few medicines have managed before, than for keeping blood sugar in check.

Behind the hype sits a simple mechanism. Known generically as semaglutide, Ozempic mimics natural gut hormones that tell the brain you’re full. Less hunger, fewer cravings — and in many patients, gradual but significant weight reduction.

Clinical trials suggest patients can lose between 15 and 20 per cent of their body weight. In medical terms, that’s no small victory: even a tenth off........

© News9Live